Smith Robert C, Lyles Judith S, Gardiner Joseph C, Sirbu Corina, Hodges Annemarie, Collins Clare, Dwamena Francesca C, Lein Catherine, William Given C, Given Barbara, Goddeeris John
Department of Medicine, Michigan State University, East Lansing, MI, USA.
J Gen Intern Med. 2006 Jul;21(7):671-7. doi: 10.1111/j.1525-1497.2006.00460.x.
There is no proven primary care treatment for patients with medically unexplained symptoms (MUS). We hypothesized that a long-term, multidimensional intervention by primary care providers would improve MUS patients' mental health.
Clinical trial.
HMO in Lansing, MI.
Patients from 18 to 65 years old with 2 consecutive years of high utilization were identified as having MUS by a reliable chart rating procedure; 206 subjects were randomized and 200 completed the study.
From May 2000 to January 2003, 4 primary care clinicians deployed a 12-month intervention consisting of cognitive-behavioral, pharmacological, and other treatment modalities. A behaviorally defined patient-centered method was used by clinicians to facilitate this treatment and the provider-patient relationship.
The primary endpoint was an improvement from baseline to 12 months of 4 or more points on the Mental Component Summary of the SF-36.
Two hundred patients averaged 13.6 visits for the year preceding study. The average age was 47.7 years and 79.1% were females. Using intent to treat, 48 treatment and 34 control patients improved (odds ratio [OR]=1.92, 95% confidence interval [CI]: 1.08 to 3.40; P=.02). The relative benefit (relative "risk" for improving) was 1.47 (CI: 1.05 to 2.07), and the number needed to treat was 6.4 (95% CI: 0.89 to 11.89). The following baseline measures predicted improvement: severe mental dysfunction (P<.001), severe body pain (P=.039), nonsevere physical dysfunction (P=.003), and at least 16 years of education (P=.022); c-statistic=0.75.
The first multidimensional intervention by primary care clinicians led to clinically significant improvement in MUS patients.
对于患有医学上无法解释症状(MUS)的患者,尚无经证实的初级保健治疗方法。我们假设初级保健提供者进行的长期、多维度干预将改善MUS患者的心理健康。
临床试验。
密歇根州兰辛的健康维护组织(HMO)。
通过可靠的图表评级程序,将连续两年高利用率的18至65岁患者确定为患有MUS;206名受试者被随机分组,200名完成了研究。
从2000年5月至2003年1月,4名初级保健临床医生开展了为期12个月的干预,包括认知行为、药物和其他治疗方式。临床医生采用行为定义的以患者为中心的方法来促进这种治疗以及医患关系。
主要终点是从基线到12个月时,SF-36精神健康综合评分提高4分或更多。
200名患者在研究前一年平均就诊13.6次。平均年龄为47.7岁,79.1%为女性。采用意向性分析,48名治疗组患者和34名对照组患者病情改善(优势比[OR]=1.92,95%置信区间[CI]:1.08至3.40;P=0.02)。相对获益(改善的相对“风险”)为1.47(CI:1.05至2.07),治疗所需人数为6.4(95%CI:0.89至11.89)。以下基线指标可预测改善情况:严重精神功能障碍(P<0.001)、严重身体疼痛(P=0.039)、非严重身体功能障碍(P=0.003)以及至少16年教育经历(P=0.022);c统计量=0.75。
初级保健临床医生进行的首次多维度干预使MUS患者在临床上有显著改善。